BANK VONTOBEL/CALL/ELI LILLY & CO/560/0.1/20.09.24 Share Price

Warrant

DE000VM3L3U1

Market Closed - Deutsche Boerse AG 11:12:13 28/06/2024 pm IST
33.62 EUR +1.97% Intraday chart for BANK VONTOBEL/CALL/ELI LILLY & CO/560/0.1/20.09.24
Current month+37.34%
1 month+43.74%
Date Price Change
28/24/28 33.62 +1.97%
27/24/27 32.97 +1.13%
26/24/26 32.6 -0.85%
25/24/25 32.88 +1.67%
24/24/24 32.34 +3.13%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 11:12 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
IssuerLogo Issuer Vontobel Vontobel
WKN VM3L3U
ISINDE000VM3L3U1
Date issued 06/10/2023
Strike 560 $
Maturity 20/09/2024 (83 Days)
Parity 10 : 1
Emission price 6.62
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 33.89
Lowest since issue 7.24
Delta0.96x
Omega 2.439
Premium1.16x
Gearing2.54x
Moneyness 1.617
Difference Strike -345.4 $
Difference Strike %-61.68%
Spread 0.02
Spread %0.06%
Intrinsic value 32.24

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
905.4 USD
Average target price
868.9 USD
Spread / Average Target
-4.03%
Consensus